Posts by Sandra Ansanay-Alex
Lonza completed its latest drug manufacturing line in Visp
The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply. Set in a 1,200 sqm cGMP facility, it includes a state-of-the-art liquid and lyophilized vial filling isolator line for multiple modalities that fulfils the GMP Annex 1 requirement for the manufacture of sterile products1.…
Read MoreW.A. de Vigier Awards 2023: 7 Western Switzerland Life Sciences Startups Selected
15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is scheduled on 20 June 2023. The Top 15 will now be further assessed through in-depth interviews with the foundation board as well as expert reports. The Top 10 are subsequently selected during two presentation…
Read MoreAn Obesity Center opens at the CHUV
The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity Consultation (Endocrinology Service), and Dr. Styliani Mantziari, head of the Bariatric Surgery Unit (Visceral Surgery Service), to combine their expertise in order to offer multidisciplinary and personalized care to patients who suffer from obesity. …
Read MoreAlithea Genomics receives CHF 500,000 from FIT
The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs. The Foundation for Technological Innovation (FIT) has chosen to give the company a Tech Growth loan of CHF 500,000. Since the Covide-19 pandemic, RNA sequencing is widely used in for fundamental research studies,…
Read MoreLunaphore raises CHF 40 million in Series D1 funding
The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology. Lunaphore Technologies S.A is a Vaud-based spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research. The startup announced that it has completed CHF 40M in Series D1 funding. The round was…
Read MoreA VR training programme for medical students supported by Innosuisse
Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology. The project is being conducted in partnership with the Geneva University Hospitals (HUG) and the University of Bern, with ORamaVR S.A. as implementation partner. Objective Structured Clinical Examinations (OSCE) are critical for the practical…
Read MoreThree new projects financed in Geneva by the FIF
Plair, Endotelix and Dr Beat Walpoth received funding from the Fongit Innovation Fund (FIF). Plair SA: Growth loan of 300’000 CHF This spin-off from the University of Geneva specializes in the development, manufacturing and marketing of professional systems for preventive environmental monitoring, using a proprietary state-of-the-art technology that forms the basis of its smart…
Read MoreSenbiosys raises more than CHF 600,000 on kickstarter
Senbiosys developed a smart ring and an application to give users inputs about their health and wellness. The EPFL spin-off raised CHF 622 672 on a Kickstarter crowdfunding campaign with more than 3465 backers. The company initially requested CHF 100,000 in funding. A smart and elegant ring to monitor your health. Iris by Senbiosys…
Read MoreTech4Eva selected 16 projects for its 2023 programme
16 projects have been selected for the 2023 programme Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative that aims at creating a long-term impact for FemTech startups and a global FemTech Community. The 2023 international cohort was selected from a total of 147 applications from 40 countries. Since the start of the…
Read MoreDebiopharm and Merck invest in artificial intelligence
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital arm of Merck, and Omnes Capital invested CHF 15.5 million in French startup Iktos By 2025, one in two drugs is expected to be discovered and developed using artificial intelligence. Iktos is a French…
Read More